ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Cancer Control Program Guidelines Developed For Payment Of Patient Costs

December 21, 1973

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

Funding opportunities listed.

October 8, 2004

DCT Board Approves Concept For BRMP Master Agreement

June 26, 1987

Executive Branch Should Improve Science Pay, NAS Says

July 16, 1993

“Harm-Reduction” Products No Proven, IOM Report Says.

March 2, 2001